Yesterday it was reported that a Director at Eagle Pharmaceuticals (EGRX – Research Report), Steven Ratoff, exercised options to buy 2,340 EGRX shares at $8.78 a share, for a total transaction value of $20.55K. The options were close to expired
Today it was reported that a Director at Eagle Pharmaceuticals Inc (EGRX – Research Report), Steven Ratoff, exercised options to buy 2,340 EGRX shares at $4.04 a share, for a total transaction value of $9,453. The options were close to